GSK and Sanofi aim for Covid-19 booster jab following successful phase 2 trial

GlaxoSmithKline and Sanofi’s Covid-19 vaccine saw strong results from its phase 2 trial and will now move on to a larger phase 3 trial as the drugs firms try to catch up with the competition.